Treatment of Advanced Hodgkin Lymphoma: The More Things Change, the More They Stay the Same

被引：12

作者：

Longo, Dan L. ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期

关键词：

INVOLVED-FIELD RADIOTHERAPY; BRENTUXIMAB VEDOTIN; STANFORD-V; OPEN-LABEL; PHASE-II; CHEMOTHERAPY; DISEASE; TRIAL; ABVD; PET;

D O I：

10.1200/JCO.2012.44.7235

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：660 / 662

页数：3

共 22 条

[1] Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma
Aleman, Berthe M. P.
Raemaekers, John M. M.
Tomsic, Radka
Baaijens, Margreet H. A.
Bortolus, Roberto
Lybeert, Marnix L. M.
Van Der Maazen, Richard W. M.
Girinsky, Theodore
Demeestere, Geertrui
Lugtenburg, Pieternella
Lievens, Yolande
De Jong, Daphne
Pinna, Antonella
Henry-Amar, Michel
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01): : 19 - 30
[2] Involved-field radiotherapy for advanced Hodgkin's lymphoma
Aleman, BMP
Raemaekers, JMM
Tirelli, U
Bortolus, R
van't Veer, MB
Lybeert, MLM
Keuning, JJ
Carde, P
Girinsky, T
van der Maazen, RWM
Tomsic, R
Vovk, M
van Hoof, A
Demeestere, G
Lugtenburg, PJ
Thomas, J
Schroyens, W
De Boeck, K
Baars, JW
Kluin-Nelemans, JC
Carrie, C
Aoudjhane, M
Bron, D
Eghbali, H
Smit, WGJM
Meerwaldt, JH
Hagenbeek, A
Pinna, A
Henry-Amar, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (24) : 2396 - 2406
[3] BONADONNA G, 1975, CANCER, V36, P252, DOI 10.1002/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO
[4] 2-7
[5] CURABILITY OF ADVANCED HODGKINS-DISEASE WITH CHEMOTHERAPY
DEVITA, VT
SIMON, RM
HUBBARD, SM
YOUNG, RC
BERARD, CW
MOXLEY, JH
FREI, E
CARBONE, PP
CANELLOS, GP
[J]. ANNALS OF INTERNAL MEDICINE, 1980, 92 (05) : 587 - 595
[6] Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
Engert, Andreas
Haverkamp, Heinz
Kobe, Carsten
Markova, Jana
Renner, Christoph
Ho, Antony
Zijlstra, Josee
Kral, Zdenek
Fuchs, Michael
Hallek, Michael
Kanz, Lothar
Doehner, Hartmut
Doerken, Bernd
Engel, Nicole
Topp, Max
Klutmann, Susanne
Amthauer, Holger
Bockisch, Andreas
Kluge, Regine
Kratochwil, Clemens
Schober, Otmar
Greil, Richard
Andreesen, Reinhard
Kneba, Michael
Pfreundschuh, Michael
Stein, Harald
Eich, Hans Theodor
Mueller, Rolf-Peter
Dietlein, Markus
Borchmann, Peter
Diehl, Volker
[J]. LANCET, 2012, 379 (9828) : 1791 - 1799
[7] Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study
Engert, Andreas
Diehl, Volker
Franklin, Jeremy
Lohri, Andreas
Doerken, Bernd
Ludwig, Wolf-Dieter
Koch, Peter
Haenel, Mathias
Pfreundschuh, Michael
Wilhelm, Martin
Truemper, Lorenz
Aulitzky, Walter-Erich
Bentz, Martin
Rummel, Mathias
Sezer, Orhan
Mueller-Hermelink, Hans-Konrad
Hasenclever, Dirk
Loeffler, Markus
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) : 4548 - 4554
[8] FABIAN C, 1989, P AN M AM SOC CLIN, V8, P253
[9] LOW-DOSE INVOLVED FIELD RADIATION AFTER CHEMOTHERAPY IN ADVANCED HODGKIN DISEASE - A SOUTHWEST-ONCOLOGY-GROUP RANDOMIZED STUDY
FABIAN, CJ
MANSFIELD, CM
DAHLBERG, S
JONES, SE
MILLER, TP
VANSLYCK, E
GROZEA, PN
MORRISON, FS
COLTMAN, CA
FISHER, RI
[J]. ANNALS OF INTERNAL MEDICINE, 1994, 120 (11) : 903 - 912
[10] ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial
Federico, Massimo
Luminari, Stefano
Iannitto, Emilio
Polimeno, Giuseppe
Marcheselli, Luigi
Montanini, Antonella
La Sala, Antonio
Merli, Francesco
Stelitano, Caterina
Pozzi, Samantha
Scalone, Renato
Di Renzo, Nicola
Musto, Pellegrino
Baldini, Luca
Cervetti, Giulia
Angrilli, Francesco
Mazza, Patrizio
Brugiatelli, Maura
Gobbi, Paolo G.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 805 - 811

← 1 2 3 →